Related Experiment Video
Updated: Sep 21, 2025

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
Outcomes of HFNC Use in COVID-19 Patients in Non-ICU Settings: A Single-center Experience
Anivita Aggarwal1, Umang Arora1, Ankit Mittal1
1Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Insights
High-flow nasal cannula (HFNC) oxygen therapy can be effective for COVID-19 patients outside the intensive care unit. This study shows favorable outcomes, suggesting HFNC is a viable treatment option in non-ICU settings.
Area of Science:
- Critical Care Medicine
- Respiratory Therapy
- Infectious Diseases
Background:
- The COVID-19 pandemic necessitated exploring effective oxygenation strategies.
- Non-intensive care unit (non-ICU) settings require accessible and efficient respiratory support.
- High-flow nasal cannula (HFNC) therapy is an alternative to conventional oxygen delivery.
Purpose of the Study:
- To evaluate the outcomes of HFNC use in COVID-19 patients admitted to non-ICU wards.
- To assess the safety and efficacy of HFNC in a real-world clinical setting.
- To determine the impact of HFNC on patient recovery and resource utilization.
Main Methods:
- A single-center retrospective study was conducted.
- Patients with COVID-19 receiving HFNC in non-ICU settings were identified.
- Outcomes such as oxygenation improvement, length of stay, and need for escalation were analyzed.
Main Results:
- HFNC therapy demonstrated significant improvement in oxygenation levels.
- A low rate of escalation to invasive mechanical ventilation was observed.
- Patients treated with HFNC in non-ICU settings experienced favorable clinical outcomes.
Conclusions:
- HFNC is a safe and effective modality for managing COVID-19 patients in non-ICU environments.
- It can help optimize resource allocation by reducing ICU admissions.
- Further research should explore optimal HFNC protocols in diverse patient populations.
Abstract:
How to cite this article: Aggarwal A, Arora U, Mittal A, Aggarwal A, Singh K, Ray A, et al.Outcomes of HFNC Use in COVID-19 Patients inNon-ICU Settings: A Single-center Experience. Indian J Crit Care Med 2022;26(4):528-530.
Related Concept Videos
Administering Oxygen by Nasal Cannula
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils,...
Oxygen Delivering System I: Nasal Cannula and Face Mask
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Suctioning the Nasopharyngeal Airway
Equipment Required

